Biotechnology Fund Class Fund Investor Sentiment

RYBOX Fund  USD 56.65  0.19  0.34%   
Slightly above 54% of Biotechnology Fund's investor base is interested to short. The analysis of overall sentiment of trading Biotechnology Fund Class mutual fund suggests that many investors are impartial at this time. Biotechnology Fund's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Fund's earnings reports, geopolitical events, and overall market trends.
  
over a year ago at news.google.com         
CA Rapid Response fund not rapid for flood victims - CalMatters
Google News at Macroaxis
2 days ago at finance.yahoo.com         
Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune Inflammatory Disease...
Yahoo News
over a week ago at thelincolnianonline.com         
Monaco Asset Management SAM Buys 35,648 Shares of Nektar Therapeutics
news
over a week ago at seekingalpha.com         
Nektar stock upgraded at Oppenheimer
seekingalpha News
over a week ago at zacks.com         
Nektar Reports Q4 Earnings What Key Metrics Have to Say
zacks News
over a week ago at gurufocus.com         
Q4 2024 Nektar Therapeutics Earnings Call Transcript
Gurufocus Stories at Macroaxis
over a week ago at zacks.com         
Acquisition by Greer R Scott of 85000 shares of Nektar Therapeutics at 0.68 subject to Rule 16b-3
zacks News
over a week ago at finance.yahoo.com         
Assertio Reports Q4 Loss, Tops Revenue Estimates
Yahoo News
over a week ago at seekingalpha.com         
Nektar Therapeutics Q4 2024 Earnings Preview
seekingalpha News
over two weeks ago at finance.yahoo.com         
Recursion Pharmaceuticals Reports Q4 Loss, Lags Revenue Estimates
Yahoo News
over three weeks ago at finance.yahoo.com         
Nektar Therapeutics to Host Virtual Investor Analyst Event with Type 1 Diabetes Experts on February ...
Yahoo News
a day ago at thelincolnianonline.com         
Holderness Investments Co. Grows Stock Position in IQVIA Holdings Inc.
news
few days ago at zacks.com         
ABM Shares Decline 4 percent Despite Reporting Q1 Earnings Revenue Beat
zacks News
six days ago at thelincolnianonline.com         
IQVIA Cut to Hold at StockNews.com
news
over a week ago at gurufocus.com         
IQVIA Holdings Inc Trading Down 3.56 percent on Mar 11
Gurufocus Stories at Macroaxis
over a week ago at businesswire.com         
IQVIA recognized as a leader in IDC MarketScapes 2024 assessment for decentralized clinical trial te...
businesswire News
over a week ago at gurufocus.com         
IQVIA recognized as a leader in IDC MarketScapes 2024 assessment for decentralized clinical ...
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Keybank National Association OH Has 1.77 Million Position in IQVIA Holdings Inc.
news
over two weeks ago at kalkinemedia.com         
Can IQVIA Revolutionize Life Sciences Solutions?
news
over two weeks ago at thelincolnianonline.com         
Dana Investment Advisors Inc. Sells 50,580 Shares of IQVIA Holdings Inc.
news
over two weeks ago at finance.yahoo.com         
Earnings grew faster than the favorable 8.3 percent CAGR delivered to IQVIA Holdings shareholders ov...
Yahoo News
over a year ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over a year ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over a year ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over a year ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over a year ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over a year ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over a year ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over a year ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
a minute ago at finance.yahoo.com         
Heres What Key Metrics Tell Us About Vertex Q4 Earnings
Yahoo News
2 days ago at finance.yahoo.com         
Crunchbase Hires Ann Davis as Senior Vice President of Sales to Scale AI-Powered Market Intelligence
Yahoo News
3 days ago at zacks.com         
Vertex Pharmaceuticals Rises But Trails Market What Investors Should Know
zacks News
few days ago at finance.yahoo.com         
NVIDIA Announces Major Release of Cosmos World Foundation Models and Physical AI Data Tools
Yahoo News
few days ago at finance.yahoo.com         
2 No-Brainer Artificial Intelligence Stocks to Buy in March
Yahoo News
few days ago at aol.com         
UK must have global ambition in AI, DeepMinds Hassabis says
news
over a week ago at finance.yahoo.com         
Why Is Alkermes Down 6.6 percent Since Last Earnings Report?
Yahoo News
over a week ago at zacks.com         
Disposition of 3231 shares by Altshuler David of Vertex Pharmaceuticals at 510.0 subject to Rule 16b...
zacks News
over a week ago at benzinga.com         
A Closer Look at Vertex Pharmaceuticalss Options Market Dynamics
benzinga news
over a week ago at statnews.com         
STAT In the Boston area, biotechs hub, a slump is being acutely felt
news
over a year ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over a year ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over a year ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over a year ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over a year ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over a year ago at businesswire.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
businesswire News
over a year ago at thelincolnianonline.com         
Seagen Inc. Receives 193.00 Average PT from Analysts
news
a minute ago at zacks.com         
Regeneron Q4 Earnings and Revenues Beat Estimates
zacks News
2 days ago at finance.yahoo.com         
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update...
Yahoo News
few days ago at finance.yahoo.com         
Fabhalta Shakes Up the PNH Market in 15 Months as Soliris, Ultomiris, and Empaveli Compete and Voyde...
Yahoo News
few days ago at finance.yahoo.com         
Oncology Market Assessment Strategic Insights for Investment or Divestment DelveInsight
Yahoo News
six days ago at dragonflycap.com         
Top Trade Ideas for the Week of March 17, 2025 The Best
news
over a week ago at gurufocus.com         
Market Today Consumer Sentiment Plummets, Palantir Gains on AI Developments
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Alpine Woods Capital Investors LLC Has 1.76 Million Stock Position in Regeneron Pharmaceuticals, Inc...
news
over a week ago at marketbeat.com         
Acquisition by Schenkein David P of 166 shares of Regeneron Pharmaceuticals subject to Rule 16b-3
Marketbeat News
over a week ago at insidermonkey.com         
Is Regeneron Pharmaceuticals, Inc. the Best Pharma Stock to Buy According to Hedge Funds?
insidermonkey News
over a week ago at thelincolnianonline.com         
Regeneron Pharmaceuticals Trading 4.7 percent Higher Still a Buy?
news
a minute ago at accesswire.com         
Class Action Filed Against Moderna, Inc. Seeking Recovery for Investors - Contact Levi Korsinsky
news
a day ago at finance.yahoo.com         
Moderna, Inc. Is a Trending Stock Facts to Know Before Betting on It
Yahoo News
3 days ago at patch.com         
Construction Planned For Bismore Park Marina This Week
patch News
few days ago at finance.yahoo.com         
Corporate Insiders Buying Burst Gives Confidence to SP Bulls
Yahoo News
few days ago at thelincolnianonline.com         
Skandinaviska Enskilda Banken AB publ Cuts Stock Holdings in Moderna, Inc.
news
few days ago at cnn.com         
Any Armenia-Azerbaijan treaty must include prisoner release, says Moderna co-founder
CNN News
six days ago at marketbeat.com         
MarketBeat Week in Review 0310 - 0314
Marketbeat News
over a week ago at channelnewsasia.com         
White House withdraws vaccine critic Weldon for CDC director
news
over a week ago at bizjournals.com         
As Modernas stock plunged, two top execs got big pay package increases
bizjournals News
over a week ago at marketbeat.com         
Moderna 4 Key Reasons the CEO Just Bought 5M in Shares
Marketbeat News
a day ago at gurufocus.com         
Incyte Stock Declines Due to Clinical Trial Results
Gurufocus Stories at Macroaxis
3 days ago at thelincolnianonline.com         
Koss Olinger Consulting LLC Invests 1.68 Million in Incyte Co.
news
few days ago at seekingalpha.com         
Incyte downgraded to Neutral at Guggenheim on trial results for skin disease treatment
seekingalpha News
few days ago at investors.com         
Sarepta Therapeutics Plummets 23 percent After Gene Therapy Recipient Dies
Investors Business Daily at Macroaxis
few days ago at finance.yahoo.com         
Why Incyte Stock Is Nosediving
Yahoo News
over a week ago at finance.yahoo.com         
Chinas First IGF-1R Monoclonal Antibody Innovent Announces NMPA approval of SYCUME for the Treatment...
Yahoo News
over a week ago at finance.yahoo.com         
Incyte Up 2.6 percent Since Last Earnings Report Can It Continue?
Yahoo News
over a week ago at businesswire.com         
Incyte verffentlicht Ergebnisse der klinischen Phase-3-Studien zur Evaluierung von Ruxolitinib Creme...
businesswire News
over a week ago at businesswire.com         
Riassunto Incyte annuncia i risultati degli studi clinici di Fase 3 per la valutazione di ruxolitini...
businesswire News
over a week ago at zacks.com         
LLYINCY Olumiant Shows Superior Efficacy in Pediatric Alopecia Study
zacks News
a day ago at finance.yahoo.com         
Stereotaxis Jumps 15 percent on NVIDIAs AI-Driven Collaboration Is It a Buy Now?
Yahoo News
3 days ago at finance.yahoo.com         
Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
Yahoo News
few days ago at finance.yahoo.com         
These 2 Medical Stocks Could Beat Earnings Why They Should Be on Your Radar
Yahoo News
few days ago at finance.yahoo.com         
Computational Biology Market Projected to Reach USD 25.46 Billion by 2032 at 16.80 percent CAGR, Dri...
Yahoo News
few days ago at insidermonkey.com         
Jim Cramer on Illumina A Challenged Company That He Doesnt Prefer
insidermonkey News
over a week ago at thelincolnianonline.com         
Canaccord Genuity Group Has Lowered Expectations for Illumina Stock Price
news
over a week ago at finance.yahoo.com         
JAZZ or ILMN Which Is the Better Value Stock Right Now?
Yahoo News
over a week ago at thelincolnianonline.com         
Bender Robert Associates Sells 8,960 Shares of Illumina, Inc.
news
over a week ago at thelincolnianonline.com         
Illumina Releases FY 2025 Earnings Guidance
news
over a week ago at finance.yahoo.com         
As tariffs loom and global currency values fluctuate, goods from these top US trade partners may shi...
Yahoo News
a minute ago at thelincolnianonline.com         
AbbVie Inc. Shares Sold by Janney Montgomery Scott LLC
news
a minute ago at thelincolnianonline.com         
Silver Oak Securities Incorporated Boosts Holdings in AbbVie Inc.
news
2 days ago at benzinga.com         
AbbVie Options Trading A Deep Dive into Market Sentiment
benzinga news
3 days ago at thelincolnianonline.com         
AbbVie Inc. Shares Purchased by Horizon Investments LLC
news
few days ago at zacks.com         
Disposition of 14973 shares by Timothy Richmond of AbbVie at 210.66 subject to Rule 16b-3
zacks News
few days ago at benzinga.com         
AbbVies Elahere Cuts Death Risk By 32, Shows Consistent Survival Benefit In Long-Term Analysis For C...
benzinga news
few days ago at thefly.com         
AbbVie announces final analysis of Phase 3 MIRASOL trial ABBV
news
few days ago at finance.yahoo.com         
1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction
Yahoo News
six days ago at finance.yahoo.com         
ELAHERE Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
Yahoo News
over a week ago at thelincolnianonline.com         
AbbVie Inc. Stock Holdings Lifted by Midwest Professional Planners LTD.
news
a minute ago at thelincolnianonline.com         
Mascoma Wealth Management LLC Buys 1 Shares of Gilead Sciences, Inc.
news
2 days ago at finance.yahoo.com         
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
Yahoo News
few days ago at seekingalpha.com         
Gilead, GSK could be impacted by potential HHS HIV prevention cuts
seekingalpha News
few days ago at thelincolnianonline.com         
Disposition of 2500 shares by Andrew Dickinson of Gilead Sciences at 110.53 subject to Rule 16b-3
news
few days ago at zacks.com         
Are You a Value Investor This 1 Stock Could Be the Perfect Pick
zacks News
over a week ago at finance.yahoo.com         
Why Is Biogen Up 1.1 percent Since Last Earnings Report?
Yahoo News
over a week ago at thelincolnianonline.com         
Morgan Stanley Increases Gilead Sciences Price Target to 130.00
news
over a week ago at zacks.com         
GILD vs. VRTX Which Stock Is the Better Value Option?
zacks News
over a week ago at finance.yahoo.com         
Gilead Up 10.3 percent Since Last Earnings Report Can It Continue?
Yahoo News
over a week ago at insidermonkey.com         
Analyst Says Gilead Sciences is a Big Liquid Stock You Should Pay Attention To
insidermonkey News
a day ago at zacks.com         
Exact Sciences Down 10.6 percent Since Last Earnings Report Can It Rebound?
zacks News
3 days ago at simplywall.st         
Exact Sciences Is Carrying A Fair Bit Of Debt
Simply Wall St News at Macroaxis
over a week ago at thelincolnianonline.com         
Postrock Partners LLC Purchases New Stake in Exact Sciences Co.
news
over a week ago at gurufocus.com         
Exact Sciences Corp Shares Down 7.9 percent on Mar 13
Gurufocus Stories at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of 66723 shares by Kevin Conroy of EXACT Sciences at 22.38 subject to Rule 16b-3
Macroaxis News
over two weeks ago at thelincolnianonline.com         
Grandfield Dodd LLC Purchases 4,962 Shares of Exact Sciences Co.
news
over two weeks ago at finance.yahoo.com         
Disposition of 1055 shares by Sarah Condella of EXACT Sciences subject to Rule 16b-3
Yahoo News
over two weeks ago at thelincolnianonline.com         
Disposition of 3780 shares by Sarah Condella of EXACT Sciences subject to Rule 16b-3
news
over three weeks ago at www.macroaxis.com         
Disposition of 54 shares by Orville Jacob A of EXACT Sciences subject to Rule 16b-3
Macroaxis News
over three weeks ago at gurufocus.com         
Disposition of 13180 shares by Kevin Conroy of EXACT Sciences subject to Rule 16b-3
Gurufocus Stories at Macroaxis
a day ago at insidermonkey.com         
Does Corteva have Long Runway for Outperformance?
insidermonkey News
3 days ago at thelincolnianonline.com         
Corteva, Inc. Shares Sold by Envestnet Portfolio Solutions Inc.
news
over a week ago at finance.yahoo.com         
Acquisition by Sam Eathington of 5120 shares of Corteva subject to Rule 16b-3
Yahoo News
over a week ago at benzinga.com         
Goldman Sachs Agri Stock Picks Cortevas RD Edge, FMCs Pipeline, And Mosaics Phosphate Advantage Set ...
benzinga news
over a week ago at insidermonkey.com         
Analyst on Corteva Theres a Breakout Happening
insidermonkey News
over a week ago at benzinga.com         
Heres How Much 100 Invested In Corteva 5 Years Ago Would Be Worth Today
benzinga news
over two weeks ago at thelincolnianonline.com         
4,582 Shares in Corteva, Inc. Acquired by SBI Securities Co. Ltd.
news
over two weeks ago at finance.yahoo.com         
United States Fertilizer Market Forecast Opportunities Report 2025 U.S. Fertilizer Additives Market ...
Yahoo News
over two weeks ago at gurufocus.com         
Disposition of 4907 shares by Charles Magro of Corteva at 62.98 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Acquisition by Oconnor Judd M of 3724 shares of Corteva subject to Rule 16b-3
news
a day ago at zacks.com         
BioMarin Up 4.2 percent Since Last Earnings Report Can It Continue?
zacks News
3 days ago at finance.yahoo.com         
Disposition of 1295 shares by Erin Burkhart of Biomarin Pharmaceutical at 71.52 subject to Rule 16b-...
Yahoo News
few days ago at finance.yahoo.com         
BMRN vs. CSLLY Which Stock Should Value Investors Buy Now?
Yahoo News
few days ago at finance.yahoo.com         
Heres Why BioMarin Pharmaceutical is a Strong Growth Stock
Yahoo News
six days ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over a week ago at zacks.com         
AMRNs Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan
zacks News
over a week ago at finance.yahoo.com         
Why BioMarin Pharmaceutical is a Top Momentum Stock for the Long-Term
Yahoo News
over a week ago at finance.yahoo.com         
Wall Street Analysts Believe BioMarin Could Rally 36.57 percent Heres is How to Trade
Yahoo News
over a week ago at aol.com         
Mothers rally and urge action over access to drug
news
over a week ago at zacks.com         
EC Approves Bristol Myers Opdivo Plus Yervoy for First-Line HCC
zacks News
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
2 days ago at finance.yahoo.com         
CTI Acquires MP Productions of Little Rock, AR
Yahoo News
3 days ago at finance.yahoo.com         
Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With S...
Yahoo News
few days ago at finance.yahoo.com         
Rare Neurological Disease Treatment Market to Reach USD 115.8 Billion by 2035, Growing at 9.7 percen...
Yahoo News
few days ago at businesswire.com         
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financ...
businesswire News
few days ago at stockgumshoe.com         
Alzheimers Update and Late Winter Miscellany
news
over a week ago at finance.yahoo.com         
INOVIOs Covid-19 dMAb maintains in-vivo detection in 100 percent participants
Yahoo News
over a week ago at prnewswire.com         
X-ELIO closes six US PPAs with Cisco, Biogen, IDEXX, and Waters Corporation
prnewswire News
over a week ago at thestar.com         
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection ...
news
over a week ago at finance.yahoo.com         
IONSAZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe
Yahoo News
a minute ago at businesswire.com         
AstraZenecas Full Year and Q4 2024 results
businesswire News
2 days ago at finance.yahoo.com         
BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Q...
Yahoo News
3 days ago at finance.yahoo.com         
Molecular Glues Market to Register Stunning Growth During the Forecast Period DelveInsight
Yahoo News
few days ago at finance.yahoo.com         
Why the Market Dipped But Amgen Gained Today
Yahoo News
few days ago at zacks.com         
Amgen Exceeds Market Returns Some Facts to Consider
zacks News
few days ago at thelincolnianonline.com         
Disposition of 174 shares by Matthew Busch of Amgen at 313.71 subject to Rule 16b-3
news
six days ago at thelincolnianonline.com         
Amgen Inc. Shares Sold by Achmea Investment Management B.V.
news
over a week ago at finance.yahoo.com         
Weekly Roundup 15 Health Press Releases You Need to See
Yahoo News
over a week ago at finance.yahoo.com         
Febrile Neutropenia Research Report 2025 Market Projected to Reach USD 23.7 Billion by 2032, Driven ...
Yahoo News
over a week ago at benzinga.com         
Amgens Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year
benzinga news
Far too much social signal, news, headlines, and media speculation about Biotechnology Fund that are available to investors today. That information is available publicly through Biotechnology media outlets and privately through word of mouth or via Biotechnology internal channels. However, regardless of the origin, that massive amount of Biotechnology data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biotechnology Fund news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biotechnology Fund relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biotechnology Fund's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biotechnology Fund alpha.

Other Information on Investing in Biotechnology Mutual Fund

Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins